Metabolon is pleased to exhibit at Discovery on Target from September 25-28, 2023, in Boston, Massachusetts. Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
Visit us at Booth 321 to discover the application of metabolomics in oncology research and the clinic via global metabolomics may help unravel cancer risk factors, identify biomarkers for screening, diagnosis, and monitoring, and also provide insights into the biology and therapeutic targets.
